"Daeth yr adolygiad i'r casgliad y dylai penderfyniadau ynghylch mynediad at driniaeth i gleifion unigol gael eu seilio ar lefel y manteision clinigol disgwyliedig ac a yw'r driniaeth yn cynnig gwerth rhesymol am arian.
“The review concluded that the principle for making decisions at an individual patient level about access to a treatment should be based upon the level of expected clinical benefit and whether the treatment offers reasonable value for money.